share_log

国恩股份(002768.SZ):控股子公司东宝生物拟收购益青生物剩余股份

Qingdao Gon Technology (002768.SZ): The holding subsidiary Baotou Dongbao Bio-Tech intends to acquire the remaining shares of Yiqing Bio-Tech

Gelonghui Finance ·  Sep 11 07:30

Gelonghui, September 11 | Guoen Co., Ltd. (002768.SZ) announced that Baotou Dongbao Biotechnology Co., Ltd. (“Dongbao Biotech”) and Qingdao Yiqing Biotechnology Co., Ltd. (“Yiqing Biotech”) are all companies within the scope of the consolidated statement of Qingdao Guoen Technology Co., Ltd., and Dongbao Biotech holds 60% of the shares in Progreen Biotech. Dongbao Biotech plans to acquire all remaining shares of Yiqing Biotech held by minority shareholders in order to further integrate the resources of the company's big health business sector, give full play to the business synergy of the gelatin industry chain, and improve operation and management efficiency. Dongbao Biotech signed a “share transfer agreement” with the company and Qingdao Deyu Biotech Investment Partnership (limited partnership) (“Deyu Biotech”) in Qingdao, Shandong Province. Dongbao Biotech plans to acquire the remaining 9.64 million shares of Yiqing Biotech held by the company and Deyu Biotech (accounting for 40% of Yiqing Biotech's total share capital). After the transaction is completed, Yiqing Biotech will become a wholly-owned subsidiary of Dongbao Biotech. This transaction will not affect the scope of the company's consolidated statements.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment